HIMSHims & Hers Health, Inc.

$29.84

$14.5252 weeks$62.76

Price

$29.84-42%1Y

1M-9.6%1Y-42%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Above average

8/10

Value79

Quality68

Momentum50

Growth42

Strongest Value, weakest Growth · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

We are a consumer-first health and wellness platform focused on providing access to modern personalized health and wellness solutions to consumers. We offer access to a range of health and wellness products and services available for customers to purchase through our websites and mobile applications. The offerings generally focus on conditions where treatment typically involves use of prescription medication on a recurring basis and ongoing care from healthcare providers.

In the company’s own words · 10-K filed Feb 23, 2026 · SEC EDGAR

P/E (TTM)-

Market Cap$8.21B

1Y Return-42%

5Y Return+270%

Hims & Hers Health, Inc. (HIMS) reported revenue of $753M in Q2 2026 (quarter ended June 30, 2026), up 38% from the same quarter a year earlier. That came with a gross margin of 64% and net loss of $86M. For the full year FY2025, revenue was $2.35B (+59% year on year) and net income $128M.

Raw charts

10 series · TTM

As reported to the SEC, without any scoring.

Drug Manufacturers - Specialty & Generic

Ranks #16 of 28 by Smart Score

Compare peers

LNTH+4.0%

Lantheus Holdings, Inc.

Amneal Pharmaceuticals, Inc.

INDV-0.43%

Indivior Pharmaceuticals, Inc.

ELAN+1.7%

Elanco Animal Health Incorporated